WHITE PLAINS, N.Y., June 22 /PRNewswire/ -- With gas prices poised to rise again for the summer months, The Leukemia & Lymphoma Society (LLS) is providing some relief by offering free gas cards in July and August.
Light The Night Walk participants doing online fundraising can earn $50 worth of free gas for every $500 they raise during July and August. For every $250 raised online, $15 gas cards will be earned. The cards will be available while supplies last.
"Light The Night Walk, LLS's annual evening fundraising walk, is the nation's opportunity to pay tribute and commemorate lives touched by blood cancer," said Nancy L. Klein, chief marketing and revenue officer for LLS. "The goal of finding cures is already a great motivator, and LLS's 'Save at the Pump' promotion is just an extra way to thank participants for bringing hope to patients battling cancer."
Light The Night Walk events take place in communities around the country in the fall, with teams of co-workers, families and friends walking together in twilight holding illuminated balloons – white for survivors, red for supporters and gold to remembers those lost to cancer. Funds raised help LLS support cutting-edge research and provide critical patient services.
For more information about the gas promotion or to learn more about Light The Night, call (877) LTN-WALK or visit www.lightthenight.org/freegas.
About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society ® (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services.
Founded in 1949 and headquartered in White Plains, NY, LLS has chapters throughout the United States and Canada. To learn more, visit www.LLS.org or contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET. www.lls.org.
SOURCE The Leukemia & Lymphoma Society